CoChat

Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

CONTEXT: Women with polycystic ovary syndrome (PCOS) are known to suffer from hyperandrogenism and impaired glucose tolerance, as well as chronic inflammation, exposing them to an increased risk of cardiovascular diseases. However, the degree to which these hormonal and metabolic alterations persist after menopause (MP) is not well documented. OBJECTIVE: Our objective was to explore whether adverse metabolic and hormonal alterations persist after MP in women with PCOS. DESIGN: We conducted a cross-sectional university hospital-based study. PATIENTS AND INTERVENTIONS: Twenty-one pre-MP (n = 10) and post-MP (n = 11) women diagnosed with PCOS were compared with 29 healthy controls (pre-MP, n = 11; post-MP, n = 18). Two-hour oral glucose tolerance tests were performed, and ovarian steroid secretion capacity was assessed (human chorionic gonadotropin tests). Areas under the curves (AUC) were calculated. RESULTS: Both pre-MP and post-MP women with PCOS had increased insulin response in oral glucose tolerance tests (AUC(ins) pre-MP = 6733.7 vs. 3382.9; post-MP = 9732.1 vs. 3265.3) and were more insulin resistant than controls. Androgen secretion capacity was increased before and after MP in PCOS (AUC of androstenedione; pre-MP: 1218.4 vs. 853.2; post-MP: 1000.0 vs. 531.3). High-sensitivity C-reactive protein remained elevated after MP in PCOS (pre-MP: 1.3 vs. 0.7; post-MP: 1.4 vs. 0.9 mg/liter). Adjustment for body mass index did not alter the results except for glucose metabolism. CONCLUSIONS: The results indicate that impaired glucose metabolism, enhanced ovarian androgen secretion, and chronic inflammation observed in pre-MP women with PCOS persist after menopausal transition emphasizing life-long health risks related to this syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2011-0039

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 50 references

Cited by

See all 108

Metadata

Authors
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S.
Affiliations
  • Oulu University Hospital (FI)
  • Turku University Hospital (FI)
Corresponding author
Tapanainen, Juha S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-06
Volume
96
Issue
6
Pages
1827-1834
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2017057701
Cited by
108
References
50
Citations by year
2026: 7 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 11 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 10 · 2012: 10
FWCI
11.00
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
polycystic ovary syndrome, menopause, insulin resistance, impaired glucose tolerance, hyperandrogenism, androstenedione, chronic inflammation, C-reactive protein, cardiovascular risk, metabolic changes
MeSH terms
Analysis of Variance, Blood Glucose, Body Composition, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Follicle Stimulating Hormone, Glucose Tolerance Test, Chorionic Gonadotropin, Humans, Inflammation, Inhibins, Luteinizing Hormone, Middle Aged, Polycystic Ovary Syndrome, Sex Hormone-Binding Globulin, Postmenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS. https://app.cochat.ai/papers/10.1210/jc.2011-0039
The paper
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011). Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-0039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.